Estados financieros detallados de Serina Therapeutics, Inc. (SER): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.16, SER presenta beneficios negativos (P/E no significativo) y un ROE del -222.42%. La capitalización bursátil es de $32M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.7M | $1.4M | $1.4M | $1.7M | $54000 | $3.5M | $500000 | $3.2M | $56000 | 0 |
| Coste de Ventas | $911000 | $685000 | $841000 | $998500 | $1.3M | $3.8M | 0 | $90000 | $194000 | 0 |
| Beneficio Bruto | $755000 | $719000 | $555000 | $729500 | -$1.2M | -$333840 | $500000 | $3.1M | -$138000 | 0 |
| I+D | $7.9M | $5.3M | $5.4M | $5.3M | $3.6M | $3.8M | $1.6M | $2.4M | $7.5M | $13.2M |
| Generales y Administrativos | $5.6M | $3.9M | $5.6M | $7.9M | $5.6M | $1.3M | $1.3M | $3.9M | $9.4M | $11.0M |
| Gastos Operativos | $13.5M | $9.1M | $11.0M | $13.3M | $9.2M | $1.3M | $2.8M | $6.2M | $16.9M | $24.0M |
| Beneficio Operativo | -$12.7M | -$8.4M | -$10.4M | -$12.6M | -$10.4M | -$1.6M | -$2.3M | -$3.1M | -$17.0M | -$24.0M |
| EBITDA | -$11.9M | -$7.7M | -$7.2M | -$11.3M | -$8.7M | -$1.2M | -$2.6M | $5.9M | -$10.5M | -$18.9M |
| Gastos por Intereses | $25000 | $12000 | 0 | 0 | $404000 | $3094 | $15878 | $558000 | $526000 | $213000 |
| Beneficio Antes de Impuestos | -$17.4M | -$6.6M | -$7.7M | -$12.2M | -$10.4M | -$1.3M | -$2.7M | $5.3M | -$11.2M | -$19.2M |
| Impuestos | 0 | 0 | 0 | $148000 | 0 | 0 | 0 | 0 | 0 | $18000 |
| Beneficio Neto | -$15.5M | -$6.6M | -$7.5M | -$12.2M | -$10.9M | -$1.3M | -$2.7M | $5.3M | -$11.1M | -$19.2M |
| BPA | $-15.21 | $-6.46 | $-7.56 | $-11.47 | $-10.14 | $-0.59 | $-2.49 | $0.63 | $-1.51 | $-1.91 |
| BPA Diluido | $-15.21 | $-6.46 | $-7.56 | $-11.47 | $-10.14 | $-0.59 | $-2.49 | $0.63 | $-1.51 | $-1.91 |
| Acciones en Circulación (Diluidas) | $1.0M | $1.0M | $992721 | $1.1M | $1.1M | $1.1M | $1.1M | $8.4M | $7.4M | $10.2M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $259000 | $7.4M | $6.7M | $2.4M | $527000 | $584000 | $645000 | $7.6M | $3.7M | $3.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $308000 | $107000 | $131000 | $363000 | $326000 | $25000 | $4000 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $688000 | $7.6M | $7.9M | $4.1M | $2.3M | $2.2M | $2.5M | $7.6M | $5.7M | $6.1M |
| Inmovilizado Material | $195000 | $129000 | $90000 | $1.1M | 0 | 0 | 0 | $1.3M | $1.0M | $842000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $2.2M | $1.6M | 0 | $738000 | 0 | 0 | 0 |
| Activos Totales | $3.2M | $9.6M | $10.7M | $7.4M | $3.9M | $3.2M | $3.2M | $9.0M | $6.7M | $7.0M |
| Cuentas por Pagar | $261000 | $75000 | $150000 | $420000 | $761000 | $193000 | $568000 | $580000 | $744000 | $1.9M |
| Deuda a Corto | 0 | 0 | 0 | $428000 | $2.4M | $7.1M | $7.6M | 0 | 0 | 0 |
| Pasivos Corrientes | $25.6M | $1.3M | $2.4M | $3.3M | $5.4M | $9.0M | $10.1M | $1.4M | $2.4M | $3.6M |
| Deuda a Largo | 0 | 0 | 0 | $1.5M | $3.9M | $6.1M | $10.5M | $3.0M | 0 | $196000 |
| Pasivos Totales | $25.6M | $1.3M | $2.4M | $4.8M | $9.3M | $15.0M | $20.6M | $41.3M | $6.2M | $7.0M |
| Reservas | -$60.0M | -$66.6M | -$74.1M | -$86.2M | -$97.1M | -$105.7M | -$116.2M | -$33.2M | -$44.3M | -$63.5M |
| Patrimonio Neto | -$23.4M | $7.3M | $7.4M | $2.2M | -$5.1M | -$11.8M | -$17.2M | -$32.3M | $641000 | -$37000 |
| Deuda Total | 0 | 0 | 0 | $2.0M | $6.3M | $13.2M | $18.1M | $3.4M | $268000 | $196000 |
| Deuda Neta | -$259000 | -$7.4M | -$6.7M | -$396000 | $5.8M | $12.6M | $17.5M | -$4.2M | -$3.4M | -$2.9M |
| Capital Circulante | -$24.9M | $6.3M | $5.4M | $757000 | -$3.1M | -$6.7M | -$7.6M | $6.2M | $3.3M | $2.5M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$15.5M | -$6.6M | -$7.5M | -$12.2M | -$10.4M | -$1.3M | -$2.7M | $5.3M | -$11.2M | -$19.4M |
| Amortizaciones | $845000 | $682000 | $535000 | $951000 | $1.3M | $33368 | $61272 | $90000 | $194000 | $73000 |
| Compensación en Acciones | 0 | 0 | 0 | 0 | 0 | $82945 | $7110 | $25000 | $2.6M | $3.8M |
| Cambio en Capital Circulante | $1.3M | $776000 | $211000 | -$410000 | -$260000 | -$754791 | -$11939 | $81000 | -$3.3M | $1.5M |
| Flujo de Caja Operativo | -$8.4M | -$6.3M | -$8.0M | -$10.2M | -$7.8M | -$2.3M | -$2.1M | -$2.5M | -$17.1M | -$18.0M |
| Inversiones (CapEx) | -$23000 | -$1000 | -$1.9M | -$641000 | -$20000 | -$108434 | -$9682 | -$504000 | -$22000 | -$59000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$8.4M | -$6.3M | -$9.9M | -$10.8M | -$7.8M | -$2.4M | -$2.1M | -$3.0M | -$17.2M | -$18.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | -15.7% | -0.6% | +23.8% | -96.9% | +6316.2% | -85.6% | +530.6% | -98.2% | -100.0% | |
| Crecimiento Beneficio Neto (anual) | +57.5% | -14.0% | -62.0% | +10.6% | +88.4% | -112.1% | +296.4% | -311.4% | -72.2% | |
| Crecimiento BPA (anual) | +57.5% | -17.0% | -51.7% | +11.6% | +94.2% | -322.0% | +125.3% | -339.7% | -26.5% | |
| Cambio en Acciones (anual) | +0.0% | -2.6% | +6.8% | +1.1% | +0.6% | +0.2% | +679.9% | -12.5% | +38.5% | |
| Crecimiento FCF (anual) | +25.6% | -57.3% | -9.2% | +27.4% | +69.9% | +11.6% | -42.9% | -475.8% | -4.6% | |
| Margen Bruto | 45.3% | 51.2% | 39.8% | 42.2% | -2272.2% | -9.6% | 100.0% | 97.1% | -246.4% | |
| Margen Operativo | -764.6% | -599.5% | -748.2% | -726.8% | -19272.2% | -47.1% | -454.1% | -99.2% | -30442.9% | |
| Margen EBITDA | -713.9% | -550.9% | -515.5% | -653.1% | -16185.2% | -35.4% | -521.0% | 187.7% | -18726.8% | |
| Margen Neto | -929.9% | -468.7% | -537.4% | -703.4% | -20120.4% | -36.5% | -536.4% | 167.1% | -19894.6% | |
| Margen FCF | -507.2% | -447.7% | -708.3% | -625.1% | -14513.0% | -68.1% | -417.1% | -94.5% | -30641.1% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -1.2% | -0.0% | -0.0% | -0.0% | 0.0% | -0.0% | -0.1% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-8.29 | $-6.17 | $-9.96 | $-10.19 | $-7.32 | $-2.19 | $-1.93 | $-0.35 | $-2.33 | $-1.76 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.0M | $1.0M | $992721 | $1.1M | $1.1M | $1.1M | $1.1M | $8.4M | $7.4M | $10.2M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -222.42% |
| Rentabilidad sobre capital invertido | -116.37% |
| Rentabilidad sobre activos | -82.03% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.17 |
| Ratio corriente | 6.65 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -6.36 | -14.98 | -14.13 | -5.67 | -5.35 | -65.98 | -7.92 | 21.83 | -3.32 | -1.00 |
| P/VC | -4.21 | 13.54 | 14.24 | 31.06 | -11.37 | -3.54 | -1.24 | -3.58 | 57.52 | -526.02 |
| P/V | 59.19 | 70.23 | 75.94 | 39.86 | 1076.81 | 12.10 | 42.53 | 36.69 | 658.37 | 0.00 |
| Margen Bruto | 45.3% | 51.2% | 39.8% | 42.2% | -2272.2% | -9.6% | 100.0% | 97.1% | -246.4% | 0.0% |
| Margen Operativo | -764.6% | -599.5% | -748.2% | -726.8% | -19272.2% | -47.1% | -454.1% | -99.2% | -30442.9% | 0.0% |
| Margen Neto | -929.9% | -468.7% | -537.4% | -703.4% | -20120.4% | -36.5% | -536.4% | 167.1% | -19894.6% | 0.0% |
Empresas relacionadas: ALGS · BRNS · CVM · GNTA · GRCE · INMB · JUNS
Explorar sector: Healthcare · Biotechnology
Más secciones de SER: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones